DG
2
-6
BEN
45
3
MUR
43
3
CSX
51
-2
HON
65
-2
RRC
63
3
NTAP
64
2
MPC
47
3
XOM
47
5
ADP
64
2
PVH
52
-3
QCOM
48
-7
BIIB
26
2
GRMN
62
-3
EFX
32
2
MAS
51
4
NRG
49
-3
V
60
-6
MTB
63
-2
IR
63
3
DG
2
-6
BEN
45
3
MUR
43
3
CSX
51
-2
HON
65
-2
RRC
63
3
NTAP
64
2
MPC
47
3
XOM
47
5
ADP
64
2
PVH
52
-3
QCOM
48
-7
BIIB
26
2
GRMN
62
-3
EFX
32
2
MAS
51
4
NRG
49
-3
V
60
-6
MTB
63
-2
IR
63
3
Financhill
Back

Viking Therapeutics 10K Form

Sell
37

VKTX
Viking Therapeutics

Last Price:
53.78
Seasonality Move:
50.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive VKTX News And Ratings

See the #1 stock for the next 7 days that we like better than VKTX

VKTX Financial Statistics

Sales & Book Value

Annual Sales: --
Cash Flow: $-21.96M
Price / Cash Flow: 0
Annual Sales: $8.18
Price / Book: 6

Profitability

EPS (TTM): -0.93000
Net Income (TTM): $-99.15M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Viking Therapeutics Earnings Forecast

Key Viking Therapeutics Financial Ratios

  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 11 years have been positive in 5 years.

Viking Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: VKTX
CUSIP: 92686J
Website: vikingtherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

VKTX Technical Analysis vs Fundamental Analysis

Sell
37
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy or a Sell?